Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Epic-Beta: Esmolol in Septic Shock
NCT07313605Phase 2Not yet recruiting
- Start
- Jan 2026
- Primary completion
- Jan 2028
- Modality
- Orthosteric Ligands
01
Overview
A Phase 2 trial of esmolol in septic shock. Planned start Jan 2026; status: not yet recruiting.
02
Drugs
esmolol
03
Conditions
septic shock
Beyond the preview
Go deeper on NCT07313605.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07313605.